Category: Press Release - Page 213 - Psychedelic Alpha

Explore our new Pα+ Psychedelic Bill Tracker.

Read more about the article Field Trip Sponsors TheraPsil, a Non-Profit Advocating for Legal, Medically-Supervised, Psilocybin-assisted Psychotherapy

Field Trip Sponsors TheraPsil, a Non-Profit Advocating for Legal, Medically-Supervised, Psilocybin-assisted Psychotherapy

Post published:June 9, 2020
Post category:Press Release

Read more about the article Revive Therapeutics Provides Update on Discussions with Health Canada in Pre-CTA Meeting

Revive Therapeutics Provides Update on Discussions with Health Canada in Pre-CTA Meeting

Post published:June 9, 2020
Post category:Press Release

Read more about the article Ehave, Inc. Engages Legal Counsel for Dual Listing of its Common Stock on the Canadian Securities Exchange (CSE)

Ehave, Inc. Engages Legal Counsel for Dual Listing of its Common Stock on the Canadian Securities Exchange (CSE)

Post published:June 9, 2020
Post category:Press Release

Read more about the article Red Light Holland Closes $3M First Tranche of Private Placement

Red Light Holland Closes $3M First Tranche of Private Placement

Post published:June 9, 2020
Post category:Press Release

Read more about the article NeonMind Expands Development of Psychedelic Patent Portfolio

NeonMind Expands Development of Psychedelic Patent Portfolio

Post published:June 9, 2020
Post category:Press Release

Read more about the article PharmaDrug Announces Application for Management Cease Trade Order

PharmaDrug Announces Application for Management Cease Trade Order

Post published:June 9, 2020
Post category:Press Release

Read more about the article MindMed: Phase 2 Clinical Trial of LSD for “Suicide Headaches” Begins Treating Patients

MindMed: Phase 2 Clinical Trial of LSD for “Suicide Headaches” Begins Treating Patients

Post published:June 8, 2020
Post category:Press Release

Read more about the article Champignon Identifies Synthetic Ketamine and Psilocybin/Psilicin Metabolite Targets; Selects Dalriada to Advance NCE IP Portfolio

Champignon Identifies Synthetic Ketamine and Psilocybin/Psilicin Metabolite Targets; Selects Dalriada to Advance NCE IP Portfolio

Post published:June 8, 2020
Post category:Press Release

Read more about the article New Wave Holdings Corp Provides Funding for LSD Research Study

New Wave Holdings Corp Provides Funding for LSD Research Study

Post published:June 5, 2020
Post category:Press Release

Read more about the article Red Light Holland Unveils Psychedelic Truffle Microdosing Packs

Red Light Holland Unveils Psychedelic Truffle Microdosing Packs

Post published:June 4, 2020
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond. Psy Alpha Ltd is a company registered in England and Wales (16989109).

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.